CytoMed Therapeutics Limited Ordinary Shares (GDTC) — Strategic Asset Allocation Index
CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a Strategic Asset Allocation Index of 0.3% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $18.21K) total $18.21K, measured against net assets of $6.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check GDTC asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
CytoMed Therapeutics Limited Ordinary Shares Strategic Asset Allocation Index (2019–2025)
This chart shows how CytoMed Therapeutics Limited Ordinary Shares's Strategic Asset Allocation Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at 0.3%, representing strategic assets of $18.21K against net assets of $6.85 Million USD. See financial flexibility index of CytoMed Therapeutics Limited Ordinary Sh to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for CytoMed Therapeutics Limited Ordinary Shares (2019–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for CytoMed Therapeutics Limited Ordinary Shares from 2019 to 2025, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see GDTC stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.3% | $18.21K | $- | $18.21K | $6.85 Million | ▼ -2.2 pp |
| 2024 | 2.4% | $220.95K | $- | $220.95K | $9.04 Million | ▲ +0.7 pp |
| 2023 | 1.7% | $195.07K | $- | $195.07K | $11.27 Million | ▼ -459.1 pp |
| 2022 | 460.8% | $2.71 Million | $2.47 Million | $239.42K | $589.03K | ▲ +354.2 pp |
| 2021 | 106.6% | $2.77 Million | $2.50 Million | $272.97K | $2.60 Million | ▼ -376.0 pp |
| 2020 | 482.6% | $2.30 Million | $2.30 Million | $0.00 | $476.83K | ▲ +361.9 pp |
| 2019 | 120.7% | $2.34 Million | $2.34 Million | $- | $1.94 Million | — |